Transdermal delivery of Minoxidil using HA-PLGA nanoparticles for the treatment in alopecia

BACKGROUND: Alopecia has become a very common disease that many people around the world are suffered. Minoxidil (MXD) is the most well-known commercialized drug in its treatment. However, in the case of MXD administration, there are some problems with low efficiency of transdermal delivery and addit...

Descripción completa

Detalles Bibliográficos
Autores principales: Jeong, Woo Yeup, Kim, Sodam, Lee, So Yun, Lee, Hyeseon, Han, Dong Wook, Yang, Seung Yun, Kim, Ki Su
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6824046/
https://www.ncbi.nlm.nih.gov/pubmed/31695925
http://dx.doi.org/10.1186/s40824-019-0164-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6824046/
https://www.ncbi.nlm.nih.gov/pubmed/31695925
http://dx.doi.org/10.1186/s40824-019-0164-z

Ejemplares similares